These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 32207033)

  • 21. Patients with More Severe IBD Get Clostridioides difficile Rather than Clostridioides difficile Increasing the Severity of IBD.
    Varma S; Faye AS; Kannan A; Lawlor G; Verma A; Axelrad J; Freedberg DE
    Dig Dis Sci; 2021 Sep; 66(9):3113-3123. PubMed ID: 32729015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.
    Nitzan O; Elias M; Chazan B; Raz R; Saliba W
    World J Gastroenterol; 2013 Nov; 19(43):7577-85. PubMed ID: 24282348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of inflammatory bowel disease with
    D'Aoust J; Battat R; Bessissow T
    World J Gastroenterol; 2017 Jul; 23(27):4986-5003. PubMed ID: 28785153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Prevalence and Risk Factors of
    Song EM; Choi A; Kim S; Jung SH
    J Korean Med Sci; 2023 Dec; 38(47):e359. PubMed ID: 38050911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of superimposed Clostridium difficile infection in Crohn's or ulcerative colitis flares in the outpatient setting.
    Garcia PG; Chebli LA; da Rocha Ribeiro TC; Gaburri PD; de Lima Pace FH; Barbosa KVBD; Costa LA; de Almeida Cruz W; de Assis IC; Moraes BRM; Zanini A; Chebli JMF
    Int J Colorectal Dis; 2018 Sep; 33(9):1285-1294. PubMed ID: 29926235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-Clostridium difficile Bacterial Infections Are Rare in Patients With Flares of Inflammatory Bowel Disease.
    Hanada Y; Khanna S; Loftus EV; Raffals LE; Pardi DS
    Clin Gastroenterol Hepatol; 2018 Apr; 16(4):528-533. PubMed ID: 29037938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicenter study of the epidemiology of Clostridioides difficile infection and recurrence in southern Brazil.
    Maestri AC; Raboni SM; Morales HMP; Ferrari LF; Tuon FFB; Losso A; Marconi C; Nogueira KDS
    Anaerobe; 2020 Aug; 64():102238. PubMed ID: 32717474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease.
    Ananthakrishnan AN; Guzman-Perez R; Gainer V; Cai T; Churchill S; Kohane I; Plenge RM; Murphy S
    Aliment Pharmacol Ther; 2012 Apr; 35(7):789-95. PubMed ID: 22360370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors and clinical outcome of Clostridium difficile infection in patients with IBD: A single-center retrospective study of 260 cases in China.
    Gu YB; Zhang MC; Sun J; Lv KZ; Zhong J
    J Dig Dis; 2017 Apr; 18(4):207-211. PubMed ID: 28251812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcomes for Clostridioides difficile associated diarrhea in inflammatory bowel disease patients versus non-IBD population: A retrospective cohort study.
    Drozdinsky G; Atamna A; Banai H; Ben-Zvi H; Bishara J; Eliakim-Raz N
    Medicine (Baltimore); 2023 Feb; 102(6):e32812. PubMed ID: 36820599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent trends and risk factors associated with Clostridioides difficile infections in hospitalized patients with inflammatory bowel disease.
    Spartz EJ; DeDecker LC; Fansiwala KM; Noorian S; Roney AR; Hakimian S; Sauk JS; Chen PH; Limketkai BN
    Aliment Pharmacol Ther; 2024 Jan; 59(1):89-99. PubMed ID: 37873878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection.
    Solanky D; Pardi DS; Loftus EV; Khanna S
    Inflamm Bowel Dis; 2019 Feb; 25(3):610-619. PubMed ID: 30260451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE).
    Vehreschild MJGT; Taori S; Goldenberg SD; Thalhammer F; Bouza E; van Oene J; Wetherill G; Georgopali A
    Eur J Clin Microbiol Infect Dis; 2018 Nov; 37(11):2097-2106. PubMed ID: 30099637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fidaxomicin treatment for Clostridioides difficile infection in patients with inflammatory bowel disease.
    Koop AH; Travers PM; Khanna S; Pardi DS; Farraye FA; Hashash JG
    J Gastroenterol Hepatol; 2023 Nov; 38(11):1910-1916. PubMed ID: 37337469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.
    Polage CR; Gyorke CE; Kennedy MA; Leslie JL; Chin DL; Wang S; Nguyen HH; Huang B; Tang YW; Lee LW; Kim K; Taylor S; Romano PS; Panacek EA; Goodell PB; Solnick JV; Cohen SH
    JAMA Intern Med; 2015 Nov; 175(11):1792-801. PubMed ID: 26348734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clostridium difficile in inflammatory bowel disease.
    Alhobayb T; Ciorba MA
    Curr Opin Gastroenterol; 2023 Jul; 39(4):257-262. PubMed ID: 37265220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridioides difficile Infection in Pediatric Inflammatory Bowel Disease.
    Reasoner SA; Nicholson MR
    Curr Gastroenterol Rep; 2023 Nov; 25(11):316-322. PubMed ID: 37646895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis.
    Barron MR; Sovacool KL; Abernathy-Close L; Vendrov KC; Standke AK; Bergin IL; Schloss PD; Young VB
    mBio; 2022 Aug; 13(4):e0190422. PubMed ID: 35900107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does early corticosteroid therapy affect prognosis in IBD patients hospitalized with Clostridioides difficile infection?
    Bar-Yoseph H; Daoud H; Ben Hur D; Chowers Y; Waterman M
    Int J Colorectal Dis; 2020 Mar; 35(3):513-519. PubMed ID: 31927638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients.
    Hughes M; Qazi T; Berg A; Weinberg J; Chen X; Kelly CP; Farraye FA
    Inflamm Bowel Dis; 2016 Apr; 22(4):853-61. PubMed ID: 26954708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.